Quinn Opportunity Partners LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
Quinn Opportunity Partners LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$80,937
-7.6%
26,6240.0%0.01%
-16.7%
Q2 2023$87,593
-37.6%
26,624
-39.7%
0.01%
-14.3%
Q1 2023$140,314
-54.0%
44,1240.0%0.01%
-62.2%
Q4 2022$305,338
+9.3%
44,1240.0%0.04%
+15.6%
Q3 2022$279,305
+13.5%
44,124
-25.9%
0.03%
+52.4%
Q2 2022$246,000
-64.0%
59,524
-57.7%
0.02%
-27.6%
Q1 2022$683,000
-54.7%
140,824
-6.6%
0.03%
-68.5%
Q4 2021$1,507,000
-65.7%
150,824
-34.5%
0.09%
-67.3%
Q3 2021$4,397,000
-36.1%
230,100
+7.0%
0.28%
-34.3%
Q2 2021$6,876,000
-4.2%
215,000
-9.7%
0.43%
-5.7%
Q1 2021$7,176,000
+2993.1%
238,000
+18207.7%
0.45%
+1094.7%
Q4 2017$232,0001,3000.04%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 4,282,827$13,019,7941.84%
Birchview Capital, LP 455,200$1,383,8081.18%
PFM Health Sciences, LP 6,040,934$18,364,4390.86%
Lion Point Capital, LP 531,256$1,615,0180.72%
Endurant Capital Management LP 251,785$765,4260.69%
Bleichroeder LP 900,000$2,736,0000.67%
Connacht Asset Management LP 31,634$96,1670.57%
Granahan Investment Management 5,137,778$15,618,8450.56%
Frazier Life Sciences Management, L.P. 1,709,907$5,198,1170.34%
Contrarius Investment Management Ltd 1,308,002$3,9760.22%
View complete list of BLUEBIRD BIO INC shareholders